That’s the key word in a very recent headline for today’s editorial feature regarding diversified health and wellness, beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) which reported that it has closed its previously announced acquisition of Naturo Group Investments Inc. (“Naturo”).
You’ll forgive us for not bringing the news of the prospective deal to your digital door but we favor done deals to unfinished works in The EMR.
It’s a fascinating acquisition for a cannabis company positioned in a marketplace with renewed affection for the sector and now adding Naturo’s innovative plant-based mineral beverage and supplement brand, TRACE, and significant manufacturing infrastructure and international distribution networks.
The third paragraph of the release should grab any astute investor’s attention as it affirms both successful sales and a now formidable presence in the beverage market.
Take a look:
“The combination of these two emerging industry leaders creates a diversified health and wellness; beverage and natural products company, with $55M+ in assets on the balance sheet, and a global multi-channel sales and distribution network positioned for growth.”
And while that glittering $55 million should turn heads, for us the long term grabber is “a global multi-channel sales and distribution network positioned for growth.”
BevCanna’s in-house brands can now potentially leverage an established sales and distribution network of over 3,000 retail stores, via Naturo’s TRACE mineral beverage brand. There’s also a 40,000 square foot state of the art beverage manufacturing facility, 315-acres of cultivable land, a naturally alkaline spring water aquifer located on site, and of course, the suite of products in Naturo’s TRACE plant based beverage and supplement brand which also includes alkaline and sparkling water offerings.
For us, the big picture won’t just be adding two balance sheets together but rather vis-à-vis the merger, what economies of scale help margins and enhance efficiency?
And better yet, how do the now shared distribution channels generate increased product diversification, market share and revenue?
Because sometimes 1 + 1 = 3.
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Warren Buffett
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM